Among patients who have obesity-related heart failure with preserved ejection fraction (HFpEF), once-weekly semaglutide 2.4 mg (Wegovy; Novo Nordisk) induces greater weight loss in women than in men ...

HFpEF often coexists with AF but ... of persistent AF in the past 6 months (37.2% women; median left ventricular ejection fraction, 59%). Patients were randomly assigned to receive either AF ...

Most patients with HFpEF are overweight or obese ... The median age was 69 years and 56.1% were women. The median body weight and BMI at baseline were 105.1 kg and 37.0 kg/m 2, respectively.

In STEP-HFpEF DM, 616 adult patients with a BMI > 30 and HFpEF ... of Toronto and professor of preventive cardiology and women's health at St. Michael's Hospital. "There is evidence to suggest ...

Patients with HFpEF who do not have atrial fibrillation ... The patients without AF had a mean age of 70.9±7.8 years, and 58.4% were women. Among the patients with AF, the median follow-up ...

A trial found semaglutide, known under the brand names Ozempic and Wegovy, helped women ... (HFpEF), where the heart pumps normally but is too stiff to fill properly. The study involving 1,145 ...

The SUMMIT trial involved 731 adults, including 54% women, who were followed for ... was that unlike STEP-HFpEF, which measured patient-reported outcomes for patients with obesity and HF taking ...

with 26.7% women. Patients were split between the 20.3% who had paroxysmal Afib and 79.7% with persistent or long-standing persistent Afib. HFrEF and HFpEF accounted for 63.0% and 37.0% of ...

Patients with LVEF of 40% or ... evidence that an MRA is beneficial in HFmrEF/HFpEF," according to Professor Scott Solomon, of Brigham and Women's Hospital in Boston, US, who is principal ...

Mavacamten, a drug initially developed to treat hypertrophic cardiomyopathy, has shown signs of reducing heart stress in patients with heart failure with preserved ejection fraction. Heart failure ...

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger ... (not restricted to breast cancer survivors), older women were at greater risk of ...